Randomized, double-blind, placebo-controlled study to evaluate efficacy of novel pan-GI prokinetic in patients with gastroparesis ROSCREA, Ireland and FREIBURG, Germany, Feb. 15, 2023 /PRNewswire/
Asia Deal Watch: Astellas Invests In Taysha, Gets Rights To Two AAV Gene Therapies informa.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from informa.com Daily Mail and Mail on Sunday newspapers.
Collaboration Provides Takeda an Exclusive License to Develop and Commercialize ZED1227/TAK-227 in the United States and Other Countries Outside of Europe, Canada, Australia and China Agreement Adds
WASHINGTON (dpa-AFX) - Takeda Pharmaceutical Company Limited (TKPHF.PK) Thursday announced partnership with Zedira and Dr. Falk Pharma GmbH to develop ZED1227/TAK-227, a Phase 2b investigational